MedPath
TGA Approval

NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule (219054)

219054

NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule

Juno Pharmaceuticals Pty Ltd

January 27, 2015

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/54d744dbbb01f764f11d142b9c58f010.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/2904b052e3ae71718f98cbd93c7b0044.pdf

Active Ingredients

neostigmine methylsulfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.